Gene · 25942
Papers3,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Counteracting FOX proteins epigenetically control the herpesvirus lytic-latent balance. | Nat Commun | 2026 | 41629328 | PubTator, text mining | PubMed |
| A recently evolved domain of the human ING1 epigenetic regulator targets mitochondria and induces senescence. | Cell Mol Life Sci | 2026 | 41617915 | PubTator, text mining | PubMed |
| SIN3A promotes lung adenocarcinoma by repressing MIR22HG/Beclin1 axis-mediated autophagy and ferroptosis. | Eur J Med Res | 2026 | 41588547 | PubTator, text mining | PubMed |
| HCMV encoded UL84 hijacks FHL2 to suppress type I interferon production and enhance viral replication. | PLoS Pathog | 2026 | 41587224 | PubTator, text mining | PubMed |
| THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progression. | Neoplasia | 2026 | 41496272 | PubTator, text mining | PubMed |
| Two Unrelated Witteveen-Kolk Syndrome Patients Presenting with Unusual Clinical Features: Dual Diagnosis and Atypical Rare Manifestation. | Mol Syndromol | 2026 | 41409308 | PubTator, text mining | PubMed |
| Emerging structural insights into PRC2 function in development and disease. | Trends Biochem Sci | 2026 | 41372031 | PubTator, text mining | PubMed |
| Personalized Treatment in Rare Genetic Syndromes: A Case-Report in Witteveen-Kolk Syndrome (SIN3A). | Mol Syndromol | 2026 | 41245232 | PubTator, text mining | PubMed |
| Protein phosphatase 2A orchestrates hematopoietic fate determination via modulation of lactate metabolism. | Haematologica | 2026 | 41230697 | PubTator, text mining | PubMed |
| Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis. | Curr Med Chem | 2026 | 40676798 | PubTator, text mining | PubMed |
| REST missense mutations reveal disrupted Re1 motif binding and co-repressor interactions in uterine fibroids. | Front Bioinform | 2025 | 41601477 | PubTator, text mining | PubMed |
| Challenges and opportunities for oncology drug repurposing informed by synthetic lethality. | NPJ Syst Biol Appl | 2025 | 41390513 | PubTator, text mining | PubMed |
| The histone modification regulator, SIN3, plays a role in the cellular response to changes in glycolytic flux. | PLoS One | 2025 | 41296708 | PubTator, text mining | PubMed |
| BRMS1L promotes chemotherapy sensitivity by inhibiting autophagy in breast cancer. | Front Genet | 2025 | 41282485 | PubTator, text mining | PubMed |
| Hierarchical regulation of cerebellar neurogenesis by Sin3A-mediated gene repression. | bioRxiv | 2025 | 41278648 | PubTator, text mining | PubMed |
| Editorial: Role of tissue-localized regulatory T cells in health and disease. | Front Immunol | 2025 | 41229434 | PubTator, text mining | PubMed |
| Identification of SIN3A as a Promising Epigenetic Target Against Allergic Rhinitis. | J Inflamm Res | 2025 | 41181361 | PubTator, text mining | PubMed |
| BAP18, as a corepressor of AR together with the SIN3A/HDAC complex, promotes AR-positive triple-negative breast cancer progression. | Cell Biosci | 2025 | 41163225 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| Mutations on the surface of HDAC1 reveal molecular determinants of specific complex assembly and their requirement for gene regulation. | Nucleic Acids Res | 2025 | 40966515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25942/papers?page=3